PharmaLundensis AB
Develops treatments designed to bind and excrete heavy metals from the body.
PHAL | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0003359710 (+5 more)
- LEI:
- 54930082I88D5N3GQ506
- Country:
- Sweden
- Address:
- Scheelevägen 22, 223 63 Lund
- Website:
- https://pharmalundensis.se/
- Sector:
- Manufacturing
Description
PharmaLundensis AB is a pharmaceutical research company that develops treatments for diseases with significant unmet needs. The company's primary project is the development of PHAL-501, a drug candidate designed to bind and excrete heavy metals such as mercury, lead, and cadmium from the body. The therapeutic works within the intestine to capture these metals, which are then removed through excretion. This mechanism is intended to prevent the drug from entering the bloodstream, suggesting a favorable safety profile with minimal side effects. PharmaLundensis is investigating this approach for its potential to provide health improvements in several conditions, including Chronic Obstructive Pulmonary Disease (COPD) and illnesses related to heavy metal toxicity.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PharmaLundensis AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PharmaLundensis AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PharmaLundensis AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-11 | Tord Staffan Håkan Skogvall | Other | Buy | 2,337 | 1,986.45 SEK |
| 2025-01-17 | SkåneÖrnen AB | Other | Buy | 121,700 | 96,143.00 SEK |
| 2025-01-17 | Tord Staffan Håkan Skogvall | Other | Buy | 10,958 | 7,999.34 SEK |
| 2024-10-14 | SkåneÖrnen AB | Other | Buy | 49,370 | 19,748.00 SEK |
| 2024-10-09 | Tord Staffan Håkan Skogvall | Other | Buy | 27,936 | 10,336.32 SEK |
| 2024-09-26 | SkåneÖrnen AB | Other | Buy | 63,000 | 29,610.00 SEK |
| 2024-09-20 | Bo Wennergren | Other | Buy | 60,000 | 27,600.00 SEK |
Peer Companies
